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Arrest of B Lymphocyte Terminal Differentiation
by CD40 Signaling: Mechanism for Lack
of Antibody-Secreting Cells in Germinal Centers
Although CD40 clearly plays a central role in the acti-
vation, expansion and survival of B cells participating
in T-dependent responses, the requirement for CD40 in
B cell terminal differentiation is less well understood.
Several in vitro experiments have suggested that CD40
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signaling promotes B cell differentiation and Ig secretion²Department of Medical Microbiology
(Spriggs et al., 1992; Grabstein et al., 1993; Maliszewskiand Sheffield Institute for Vaccine Studies
et al., 1993). However, other experiments have indirectlyUniversity of Sheffield Medical School
suggested that engagement of CD40 may actively inhibitSheffield S10 2RX
B cells from differentiating into antibody-secreting cellsUnited Kingdom
(Arpin et al., 1995; Callard et al., 1995; Silvy et al., 1996).³Department of Cell Biology
Strikingly, in vivo studies do not support the idea thatCINVESTAV-IPN
CD40 is required for B cell terminal differentiation (Ka-cp 07360
wabe et al., 1994; Han et al., 1995). Mice deficient inMexico D. F.
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(Kawabe et al., 1994), and the amount of circulating IgM‖Department of Pathology
in mice or humans that have defects in CD40 signalingStanford University
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ally, the formation of foci of antigen-specific plasma
cells after immunization is unimpaired in the absence
of CD40 signaling (Han et al., 1995).Summary
In order to reconcile these conflicting results, we di-
rectly tested the role of CD40 signaling in B cell terminalDespite extensive research, the role of CD40 signaling
differentiation. We observed that engagement of CD40in B cell terminal differentiation remains controversial.
by its cell-bound ligand actively suppressed antibodyHere we show that CD40 engagement arrests B cell
secretion in B cells by repressing the steady-state levelsdifferentiation prior to plasma cell formation. This ar-
of differentiation-specific, but not activation-specific,rest is manifested at a molecular level as a reduction
genes. This inhibition could not be overcome by B cellin mRNA levels of secretory immunoglobulin gene
mitogens, cytokines, or stimulation through the BCRproducts such as ms and J chain as well as the loss but, upon disruption of the gp39/CD40 interaction, theof the transcriptional regulator BLIMP-1. Furthermore,
inhibition was reversed and the B cells proceeded tothe inhibition of B cell differentiation by CD40 engage-
differentiate normally. These results suggest a mecha-ment could not be overcome by either mitogens or
nism for the lack of antibody-secreting cells in the germi-cytokines, but could be reversed by antibodies that
nal center which in turn allows for the selection of high-interfere with the CD40/gp39 interaction. These data
affinity antibody-forming cells.suggest that secretory immunoglobulin is not pro-
duced by B cells that are actively engaged by gp39- Results
expressing T cells.
Effect of CD40 Signaling on the Proliferation
Introduction and Differentiation of CH12 Cells
To investigate whether CD40 signaling influences the
CD40 is a member of the TNF receptor family (Smith et
terminal differentiation of B cells, we initially examined
al., 1994) and is the major costimulatory molecule on B
the murine B cell line CH12. The CH12 line used in these
cells (Grewal and Flavell, 1996). CD40 signaling triggers
studies is passaged as an in vivo tumor, but can be
a potent B cell proliferative response (Banchereau et
cultured in vitro for short-term stimulations (King et al.,
al., 1991; Armitage et al., 1993), induces the expression 1990). Unstimulated CH12 cells grow slowly in culture
of costimulatory and adhesion molecules such as B7.1, and secrete very little Ig, however a variety of mitogens
B7.2, and ICAM-1 (Bjork and Paulie, 1993; Ranheim and and cytokines including LPS, IL-5, and IL-6 can induce
Kipps, 1995), and mediates B cell clonal expansion and the proliferation and/or differentiation of these cells
survival within the germinal center (Liu et al., 1989; Han (Randall et al., 1994). To test whether CH12 cells were
et al., 1995). Engagement of CD40 by its ligand, gp39 responsive to CD40 triggering, CH12 cells were cultured
or CD154, on activated T cells is a crucial component with polyclonal anti-CD40 in either the presence or ab-
of cognate T cell help as animals deficient in either CD40 sence of a saturating dose of LPS and proliferation was
or its ligand are unable to form germinal centers or make measured at 48 hr. As seen in Figure 1A, anti-CD40
high affinity, class-switched antibodies after immuniza- stimulation greatly increased the proliferation of CH12
tion with T-dependent antigens (Castigli et al., 1994; cells in a dose-dependent fashion relative to cells stimu-
Kawabe et al., 1994; Xu et al., 1994). lated in media alone. Anti-CD40 stimulation also aug-
mented the proliferative response induced by the mito-
gen LPS.# To whom correspondence should be addressed.
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It is well established that the extent of receptor cross-
linking can alter the biological responses of stimulated
cells (Hartley et al., 1991). Therefore, we next tested
whether more extensive cross-linking of anti-CD40 anti-
bodies could induce the differentiation of CH12 cells. In
this experiment, CH12 cells were cocultured with CD32
(Fc receptor)±expressing L cells and increasing concen-
trations of monoclonal anti-CD40 antibody (1C10) in the
presence or absence of LPS. B cells were removed from
the adherent layer after 48 hr and were washed, counted
and recultured at 105 cells/ml for 6 hr todetermine secre-
tory rates. Again, CH12 cells proliferated when cultured
with anti-CD40 and the CD32-expressing L cells (not
shown). However, CD40 signaling had no positive effect
on antibody secretion either alone or in combination
with LPS (Figure 1C).
Since the natural ligand for CD40 is thought to be
expressed as an integral membrane trimer (Banner et
al., 1993), the effect of cell-bound gp39 on CH12 cell
proliferation and differentiation was next tested in a
coculture system using L cells that had been stably
transfected with gp39. Similar to what we observed with
the anti-CD40 treatments, CH12 cells cocultured on
gp39 L cells proliferated much more than those cultured
on untransfected L cells, regardless of the addition of
Figure 1. Anti-CD40 Antibodies Are Mitogenic for CH12 Cells, but other costimuli (not shown). There were striking differ-
Have No Effect on Antibody Secretion ences, however, in the amount of antibody secreted
(A) CH12 cells were cultured with increasing concentrations of rat by CH12 cells cultured with gp39-expressing L cells
polyclonal anti-CD40 in either media alone or with LPS at 50 mg/ml compared to the amount of antibody secreted by CH12
for 48 hr. Proliferation assays were performed with 5 3 104 cells/ cells cultured with anti-CD40 antibodies. CH12 cells co-
well, and cells were pulsed with 3H-thymidine at the 48 hr time point
cultured with untransfected L cells in the presence ofand harvested 4 hr later.
either LPS, IL-5, or IL-6 differentiated and secreted large(B) In a parallel experiment, antibody secretion was measured at 48
amounts of Ig relative to cells cultured in media or IL-4hr by removing CH12 cells from the cultures and then washing,
counting, and reculturing them in fresh medium at 105 cells/ml for (Figure 2A). In contrast, CH12 cells that were continu-
6 hr. Supernatants were harvested and secreted Ig was measured ously cultured with gp39 transfected L cells in the pres-
by anti-kappa ELISA. ence of LPS, IL-5, or IL-6 wereunable todifferentiate into
(C) The effects of anti-CD40 cross-linking were determined by add- antibody-secreting cells. In fact, even the background
ing increasing amounts of anti-CD40 (1C10) to cocultures of CH12
levels of Ig secretion observed in supernatants of cellscells and CD32-expressing L cells either with or without LPS (50
cultured with either media or IL-4 was reduced by cocul-mg/ml). After 48 hr CH12 cells were removed from the adherent cells,
ture with gp39-expressing cells. Furthermore, no combi-washed, and recultured at 105 cells/ml for 6 hr, and secreted Ig was
measured by anti-kappa ELISA. nation of cytokines (IL-2, IL-4, IL-5, IL-6, or IL-10), LPS,
anti-Ig, or antigen was able to overcome the inhibition
mediated by gp39 (not shown).In a parallel experiment, we examined whether en-
We hypothesized that the ability of cell-bound gp39gagement of CD40 on CH12 cells could influence anti-
to block B cell differentiation might be related to thebody secretion. CH12 cells were cultured as described
amount of gp39 found in the coculture system. We ad-above, and after 48 hr the stimulated cells were washed,
dressed this issue in two ways. First, the number ofcounted, and recultured at 105 cells/ml for an additional
gp39-expressing cells in the cultures were altered by6 hr. The amount of secreted Ig in the supernatants of
mixing L cells and gp39-expressing L cells in differentthe 6 hr cultures was then determined by anti-kappa
ratios, while keeping the total number of cells constant.ELISA. This basic protocol was utilized for all our experi-
CH12 cells were then cultured on these mixed mono-ments and allowed us to measure Ig secretion on a per
layers in the presence or absence of LPS, and the secre-cell basis. As seen in Figure 1B, CH12 cells cultured in
tory rates were determined after 48 hr as describedmedia alone, or with increasing amounts of anti-CD40
above. As seen in Figure 2B, the inhibition of Ig secretionproduced low background levels of secreted immuno-
by CH12 cells was dependent on the number of gp39-globulin. Furthermore, even though LPS-stimulated cells
expressing L cells in theculture, with half maximal inhibi-secreted large amounts of Ig, the amount of secreted
tion of Ig secretion observed when as few as 12% ofantibody was not substantially altered by the addition
the L cells expressed gp39.of anti-CD40. Similar results were observed when either
Next, the amount of cell-bound gp39 needed to inhibitsoluble gp39-CD8 fusion protein (Lane et al., 1993), or
B cell differentiation was determined by producing amonoclonal anti-CD40 (Heath et al., 1993) were used in
series of stably transfected gp39-expressing clones ofplace of the polyclonal anti-CD40 (not shown). Together,
the BW5147 thymoma. As determined by FACS, thethese data demonstrate that, although CD40 engage-
transfected clones expressed gp39 with mean fluores-ment is mitogenic for CH12 cells, it is insufficient to
induce differentiation and antibody secretion. cent intensities (MFI) ranging from 2 to 13 relative to
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Figure 2. CD40 Engagement by Cell-Bound
gp39 Inhibits the Differentiation of CH12 Cells
Regardless of Other Stimuli
(A) CH12 cells were cocultured at a 1:1 initial
ratio with either untransfected L cells or with
gp39-expressing L cells in the presence of
media alone, LPS (50 mg/ml), IL-4 (100 U/ml),
IL-5 (50 U/ml), or IL-6 (50 ng/ml) as indicated
for 48 hr. CH12 cells were then removed from
the adherent L cells, washed, counted, and
replated in fresh medium at 105 cells/ml for an
additional 6 hr. Supernatants were collected
and antibody concentrations were deter-
mined by anti-kappa ELISA.
(B) The dose response of CH12 cells to cell-bound gp39 was investigated by coculturing CH12 cells with mixtures of L cells and gp39-
expressing L cells. The total number of fibroblasts seeded in each culture was constant at a 1:1 ratio with CH12 cells; however, the percentage
of gp391 cells ranged from 100% to 0%. Cultures were maintained in either media or LPS for 48 hr when CH12 cells were removed, washed,
and recultured. Secreted Ig was measured by anti-kappa ELISA.
(C) A panel of gp39-transfected BW5147 subclones that expressed differing levels of gp39 was established. The level of gp39 expression on
the various clones was determined by FACS analysis and is represented as mean fluorescence intensity (MFI). The individual clones were
then cocultured at 1:1 ratios with CH12 cells in either media or LPS. After 48 hr cells were washed and recultured for an additional 6 hr and
secreted Ig was measured by anti-kappa ELISA.
untransfected cells that were set at an MFI of 0. Interest- on normal activated T cells (not shown). These trans-
fected lines were then used in coculture experimentsingly, the expression of gp39 on all of the individual
with CH12 cells to determine if the inhibition of differenti-BW5147 transfectants was found to be less than or
ation by gp39 was cell-type specific. As shown in Figuresimilar to the amount of gp39 expressed by activated
3A, CH12 cells cultured with any of the untransfectedCD41 splenic T cells (not shown), indicating that the cell
parental cell lines in media alone did not differentiatelines expressed physiologically relevant levels of gp39.
into antibody-secreting cells, while those cultured withThese clones were then used in coculture experiments
LPS secreted large amounts of antibody. Furthermore,with CH12 cells and the ability of CH12 cells to secrete
the levels of Ig secretion found in the coculture systemantibody was plotted relative to the gp39 expression on
were comparable to those observed when CH12 cellseach of the clones. In Figure 2C, it is clear that the
were cultured in the absence of the other cells (Figureinhibition of CH12 differentiation is dependent on the
3A, CH12 alone), demonstrating that none of the un-level of gp39 expression, with the clones expressing
transfected cell lines inhibited or stimulated CH12 cellhigh and moderate levels of gp39 inhibiting essentially
differentiation on their own. In contrast to the results withall Ig secretion, while the clones that expressed low
untransfected cells, the majority of the gp39-transfectedlevels of gp39 were more variable in their ability to inhibit
cell lines (6/7) completely inhibited differentiation whenIg secretion. Taken together, these data demonstrate
cocultured with CH12 cells in the presence of LPS (Fig-that neither anti-CD40 antibodies nor the gp39-express-
ure 3B). The only exception to this was the gp39-ing cells were able to promote B cell differentiation alone
transfected Cos-7 cell line, which did not inhibit LPS-or in combination with other stimuli. Instead, engage-
induced antibody secretion by CH12 cells. Interestingly,ment of CD40 on CH12 cells by cell lines that constitu-
the transfected Cos-7 cells expressed very low levelstively express gp39 appeared to inhibit terminal differen-
of gp39 (not shown), suggesting that this cell line mighttiation even when the cells were cultured with cytokines
not express sufficient gp39 to inhibit differentiation.or mitogens that would normally induce antibody secre-
To demonstrate whether the CD40/gp39 interactiontion (Randall et al., 1992a, 1994).
was directly responsible for the inhibitory effect on dif-
ferentiation, the gp39-specific monoclonal antibody,
Cellular Components Required for Inhibition MR-1 (Noelle et al., 1992a), was used to block gp39/
of B Cell Differentiation by Cell Bound gp39 CD40 interaction. We found that MR-1 had no effect on
The difference between the ability of anti-CD40 antibod- the ability of CH12 cells to differentiate when cocultured
ies and cell-bound gp39 to inhibit B cell differentiation with untransfected cells (Figure 3C); however, the inhi-
suggested that the transfected cell lines may contribute bition of differentiation mediated by any of the gp39-
other factors, in addition to gp39, that were required to expressing cell lines was completely reversed by the
mediate the inhibitory effect. To investigate this possibil- addition of the gp39-blocking antibody (Figure 3D).
ity, we stably expressed murine gp39 in a total of seven This indicated that the transfected cell lines mediated
different cell lines derived from various tissues and spe- their suppressive effect on antibody production directly
cies. The cell lines tested included BW5147 (murine thy- through gp39 and not some secondary effect. Interest-
moma), 3T3 (murine fibroblast), 293 (human fibroblast), ingly, if the blocking antibody was added at 24 hr after
BHK (hamster kidney), Cos-7 (monkey kidney), CHO the initiation of the cocultures and the secretory rates
(hamster ovary), and L cells (murine fibroblasts). The were measured at 48 hr, a substantial recovery in the
gp39-transfected cells were examined by FACS and the secretory capacity of the CH12 cells was observed (Fig-
surface expression of gp39 on each of these lines was ures 3E and 3F). Together, these experiments demon-
strate that gp39 directly mediates the suppressive effectfound to be either less than or roughly equivalent to that
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Figure 3. The Inhibition of CH12 Cell Differ-
entiation Is Mediated by the Interaction of
gp39/CD40 and Is Cell-Type Independent
CH12 cells were cocultured with 293, Cos-7,
L, BHK, CHO, 3T3, or BW5147 cells (A, C, and
E) or with their gp39-transfected counterparts
(B, D, and F) either in media alone (gray bars)
or with 50 mg/ml LPS (black bars). CH12 cells
were also cultured in either media or LPS in
the absence of other cell types (CH12 alone).
In (C) and (D), 50 mg/ml of the gp39-blocking
antibody MR-1 was added at the beginning
of the culture. In (E) and (F), 50 mg/ml of MR-1
was added 24 hr after the initiation of the
cocultures. In all panels, CH12 cells were col-
lected after 48 hr, washed, counted, and re-
cultured in fresh media with no additional
stimuli for an additional 6 hr. Secreted anti-
body in the 6 hr supernatant was measured
by anti-kappa ELISA.
on B cell differentiation and that the CD40/gp39 interac- LPS (Figure 4A). This result was not surprising, as CH12
cells can differentiate in response to cytokines presenttion must be actively maintained in order mediate this
inhibition. In addition, the inhibition of B cell differentia- in supernatants of stimulated T cells (Swain et al., 1988;
Randall et al., 1994). Thus, once the inhibitory CD40tion by CD40 is only observed when the natural ligand
for CD40 is expressed on the cell surface, although the signal was blocked, the CH12 cells were free to differen-
tiate in response to either LPS or the T cell-derivedcell type that expresses gp39 appears to be relatively
unimportant. cytokines.
Since CH12 is a transformed cell line and may beFrom our current knowledge of gp39 expression, B
cells are most likely to encounter gp39 on activated T unusual in its response to CD40 engagement, the conse-
quences of CD40 signaling on the terminal differentia-cells (Armitage et al., 1992; Noelle et al., 1992b; Gauchat
et al., 1993). Although our panel of gp39-transfected cell tion of normal B cells were also examined. In order to
perform this experiment properly, it was important tolines did include one T cell line (BW5147) that was able
to inhibit differentiation, all of the cell lines tested consti- identify physiologic stimuli that could induce the differ-
entiation of resting B cells without requiring a CD40tutively expressed gp39. To determine whether our ob-
servations with the transfected cell lineswere physiolog- signal to first activate the cells. Thus, we used LPS,
which can induce both activation and differentiation ofically relevant, we tested the ability of normal activated
CD41 T cells to inhibit B cell differentiation as a result B cells, as well as various combinations of cytokines
and/or anti-Ig that might be expected to induce both Bof gp39 expression. Purified CD41 cells were cocultured
with CH12 cells in anti-CD3-coated wells with media cell activation and differentiation. Purified normal splenic
B cells were cocultured with either L cells or gp39 Lalone, LPS, MR-1, or the combination of LPS and MR-1
for 48 hr and secreted Ig was measured as described cells in the presence of the indicated combinations of
cytokines, anti-Ig, and LPS, and Ig secretion was mea-above. As seen in Figure 4A, neither unstimulated nor
LPS-activated CH12 cells were able to secrete antibody sured after 4 days. Again, Ig secretion was measured
on a per cell basis in order to separate any differenceswhen cultured with anti-CD3-activated T cells. However,
when gp39/CD40 interactions were disrupted with MR1, in the viability and expansion of B cells from the mea-
surement of B cell differentiation.the CH12 cells differentiated and secreted large amounts
of antibody. Interestingly, when MR-1 was present, Although B cells cocultured with untransfected L cells
in the presence of anti-m and IL-4 became activated,CH12 cells secreted Ig in cultures that did not contain
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Figure 4. The Inhibitory Effects of gp39 Can
Be Mediated by Activated CD41 T Cells and
Can Block Antibody Secretion by Activated
and Germinal Center B Cells
(A) Purified resting CD41 splenocytes were
cocultured with CH12 cells in anti-CD3
coated wells with media alone, LPS, MR-1,
or LPS plus MR-1. After 48 hr, cells were col-
lected, washed, and recultured for an addi-
tional 6 hr. Secretory Ig was determined by
anti-kappa ELISA.
(B) Purified splenic B cells were cocultured
with monolayers of either L cells or gp39-
transfected L cells in the presence of LPS,
anti-m plus IL-4, IL-2 plus IL-10, or a combina-
tion of anti-m, IL-2, IL-4, and IL-10. After 4
days, 105 cells from each culture were washed and recultured in fresh media without any additional stimuli for 6 hr. Secreted antibody was
assayed by anti-kappa ELISA. LPS was used at 20 mg/ml, anti-m (Fab92 from goat) at 20 mg/ml, IL-2 at 100 U/ml, IL-4 at 100 U/ml, and IL-10
at 100 U/ml.
(C) Germinal center B cells were isolated by negative selection from the spleens of mice immunized 12 days previously with NP-KLH. These
cells were then cultured for 48 hr on either L cells or gp39 L cells in the presence of the indicated cytokine combinations. Supernatants were
collected at 48 hr and the presence of NP-specific Ig was determined by ELISA. IL-2 was used at 100 U/ml, IL-4 at 100 U/ml, IL-5 at 100 U/
ml, IL-6 at 50 ng/ml, IL-10 at 100 U/ml, and LPS at 20 mg/ml.
these cells did not secrete appreciable amounts of anti- Effect of CD40 Signaling on Gene Expression
To examine the molecular basis for our observations,body (Figure 4B). Additionally, B cells cocultured with
untransfected L cells, and a combination of IL-2 and IL- RNA was isolated from CH12 cells that had been stimu-
lated to differentiate in thepresence or absence of gp39-10 also did not secrete significant amounts of antibody
(Figure 4B). Antibody secretion was observed, however, expressing L cells. Northern blots were then probed with
cDNAs for B cell±specific activation and differentiationfrom B cells that were cocultured with untransfected L
cells in the presence of either LPS or the combination genes. As seen in Figure 5, the expression of IgM heavy
chain (m) correlated with the observed secretory ratesof anti-m, IL-2, IL-4, and IL-10 (Figure 4B). In contrast,
B cells that were cocultured with gp39-expressing L of CH12 cells (Figure 2A). For example, CH12 cells that
were cocultured on untransfected L cells in media alonecells in the presence of LPS or the combinations of
cytokines and anti-m did not secrete antibody (Figure
4B), even though these cells proliferated and survived
better than their counterparts that were cocultured with
untransfected L cells (not shown). These results were
entirely consistent with the results from the CH12 model
and suggested that the arrest of terminal differentiation
by engagement of CD40 on activated B cells is a general
property of B cells.
Since the formation and maintenance of germinal cen-
ters is dependent on CD40 signaling (Xu et al., 1994;
Han et al., 1995), we next tested if germinal center B cells
are sensitive to the inhibitory effects of CD40 signaling.
Germinal center B cells were enriched from NP-KLH
immunized mice and were cocultured for 48 hr on either
L cells or gp39 L cells with the indicated combinations
of cytokines or LPS. After 48 hr, supernatants were ana-
lyzed for NP-specific, lambda-containing Ig. As shown
in Figure 4C, many combinations of cytokines or LPS
could induce antibody secretion by germinal center B
cells. However, in all cases antibody secretion was dra-
matically reduced in the presence of gp39-expressing
cells. The data shown are representative of multiple ex- Figure 5. Gene Expression in gp39-Stimulated CH12 Cells
periments, and although we have not examined all com- CH12 cells were cocultured with either L cells or gp39 L cells in the
binations of cytokines, we found that germinal center B presence of LPS (50 mg/ml), IL-4 (100 U/ml), IL-5 (50 U/ml) or IL-6
cells could not differentiate after stimulation with single (50 ng/ml). CH12 cells were removed from the adherent layers after
48 hr and RNA was extracted. Twenty micrograms total RNA wascytokines (IL-2, IL-4, IL-5, IL-6, or IL-10) but could differ-
loaded per sample and analyzed by Northern blotting. Blots wereentiate with some double combinations and many triple
probed with cDNAs for m heavy chain constant region, J chain,combinations of cytokines (not shown). Importantly,
BLIMP-1, and CHO-B as a loading control. RNA from the plasmacy-
there were no conditions tested inany experiment where toma J558 serves as a positive control for the expression of BLIMP-1
germinal center Bcells cocultured with gp39-expressing and J chain while RNA from L cells serves as a negative control for
cells secreted more Ig than cells cocultured with un- all B cell±specific mRNAs. Arrows indicate the alternate forms of m
mRNA (mm, upper arrow; ms, lower arrow).transfected L cells.
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or with IL-4 expressed low levels of m mRNA with an
equimolar distribution of the secretory (ms) and mem-
brane forms (mm), typical of an activated but nondifferen-
tiated B cell (Early et al., 1980). When CH12 cells were
cocultured with untransfected L cells in the presence
of LPS, IL-5, or IL-6, however, theabundance of m mRNA
was dramatically increased, and the ratio of mm to ms
shifted such that ms mRNA was increased while mm
stayed at a relatively constant level (Figure 5). In con-
trast, very little ms mRNA was expressed by CH12 cells
that had been cocultured with gp39-expressing L cells,
regardless of the costimulus. In addition, the ratio of mm
to ms in these cells usually remained equimolar (IL-5 and Figure 6. LPS and IL-5 Signaling Pathways Are Functional in CH12
IL-6) or mm predominated over ms (media and IL-4). Thus, Cells Cocultured on gp39-Expressing L Cells
although m mRNA was not completely eliminated by RNA samples were the same as in Figure 5. Northern blots with 20
mg total RNA/sample were probed with cDNAs for either the LTRcoculture with gp39-expressing L cells, the levels of ms
region of Mtv-9 or the mitochondrial enzyme CHO-B as a loadingwere dramatically reduced.
control.The effect of CD40 engagement on J chain mRNA
levels after IL-5 or IL-6 stimulation was also tested, since
J chain, unlike m, is a protein that is only utilized in the
with gp39 L cells could be that CD40 ligation by gp39assembly of the secreted forms of IgM and IgA (Lamson
interrupts the signaling pathways utilized by the recep-and Koshland, 1984; Randall et al., 1992b) and its ex-
tors for LPS, IL-5, and IL-6. To assess whether the LPSpression is often a good indicator of the differentiation
and IL-5 signaling pathways were intact in CD40-stimu-state of B cells. As expected, when CH12 cells were
lated cells, we examined the effect of the CD40 signalingcocultured with untransfected L cells in the presence
on the expression of genes that are unrelated to immu-of either IL-5 or IL-6, J chain mRNA levels increased
noglobulin secretion. We previously published that thedramatically compared to cells cocultured with L cells
transcription of mouse mammary tumor virus (MMTV)in media alone (Figure 5). In sharp contrast, CH12 cells
proviral genes is up-regulated upon B cell activation,cultured with either IL-5 or IL-6 in the presence of gp39-
particularly after LPS or IL-5 stimulation (Randall et al.,expressing L cells were almost totally devoid of J chain
1994). Therefore, the expression of MMTV mRNA wasmRNA.
examined in CH12 cells that were stimulated with LPSSince the terminal differentiation of B cells (including
or IL-5 in the presence or absence of CD40 engagementthe expression of J chain) has been suggested to be
by gp39-expressing L cells. As expected, we observedunder the control of the zinc finger protein BLIMP-1
that both LPS and IL-5, but not media or IL-4, induced(Turner et al., 1994), the expression of BLIMP-1 was
a dramatic increase in the steady-state levels of MMTVexamined in stimulated CH12 cells. In unstimulated or
mRNA in CH12 cells that were cocultured with un-IL-4-stimulated CH12 cells cocultured with untrans-
transfected L cells (Figure 6). Interestingly, however,fected L cells, the expression of BLIMP-1 was detect-
equivalently elevated levels of MMTV mRNAs were ob-able but very low (Figure 5). This was not unexpected,
served in IL-5- and LPS-stimulated CH12 cells that hadsince 1%±5% of unstimulated CH12 cells will normally
been cocultured with gp39 L cells. We also observedspontaneously differentiate in culture (Randall et al.,
that MMTV mRNA levels were increased in CH12 cells1994) and probably contribute to the low average level
cocultured with the combination of IL-4 and gp39-of BLIMP-1 mRNA expression. However, the expression
expressing L cells, even though addition of either ofof BLIMP-1 was increased in CH12 cells cocultured with
these stimuli alone did not affect MMTV expression.untransfected L cells and either LPS, IL-5, or IL-6, and
Thus, although signaling through CD40 actively re-was equivalent to the expression of BLIMP-1 in the plas-
pressed the expression of secretory gene products suchmacytoma, J558, which represents a pure population
as J chain and ms, it did not interfere with, and in someof terminally differentiated antibody-secreting B cells.
cases actually enhanced, the expression of genes thatWhen CH12 cells were cocultured with gp39 L cells in
are unrelated to B cell differentiation.the presence of IL-5, IL-6, or LPS, BLIMP-1 mRNA levels
were dramatically reduced, and even the low levels of
DiscussionBLIMP-1 mRNA found in cells cultured in media or IL-4
alone were decreased in the presence of gp39 L cells
Effect of CD40 Signaling on B Cell(Figure 5). Therefore, the steady-state levels of ms and
Terminal DifferentiationJ chain mRNAs, as well as the mRNA of one of their
Since the CD40/gp39 interaction is a central componentimportant transcriptional regulators, BLIMP-1, are down-
of cognate T cell help (Noelle et al., 1992b), many investi-regulated in CH12 cells while CD40 is engaged. Identical
gators have suggested that, in addition to its ability tochanges in gene expression were observed when nor-
induce B cell activation and proliferation,CD40 signalingmal B cells were stimulated with LPS or with combina-
also induces B cell terminal differentiation, particularlytions of cytokines and anti-Ig in the presence of gp39-
in combination with cytokines (Armitage et al., 1993;expressing cells (not shown).
Durandy et al., 1993; Maliszewski et al., 1993). In con-One explanation for the inability of CH12 cells to differ-
entiate in response to LPS, IL-5, or IL-6 when cocultured trast, several published reports have shown that CD40
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signaling maintains memory B cells in an undifferenti- a specific repression of the steady-state levels of the
ated state (Arpin et al., 1995; Callard et al., 1995; Lane mRNAs for ms and J chain, as well as one of their regula-
et al., 1995; Silvy et al., 1996), suggesting the possibility tory factors, BLIMP-1 (Figure 5). Given that CD40 signal-
that CD40 signaling may directly prevent B cell terminal ing induced B cell activation and proliferation (Figure 1)
differentiation. Here we have directly tested this hypoth- while preventing differentiation (Figures 2 and 3), one
esis and found that CD40 signaling is not only insuffi- would predict that only genes involved in secretory Ig
cient to induce plasma cell formation, but actively ar- synthesis should be repressed. In this regard, the ex-
rests B cells at a stage prior to terminal differentiation, pression of mm mRNA and MMTV mRNA provide satis-
even in thepresence of cytokinesor mitogens that would fying controls. Although ms levels were dramatically re-
normally trigger differentiation and antibody secretion. duced upon CD40 engagement, the amount of mm mRNA
Although these results appear to be contradictory to stayed relatively constant (Figure 5). In addition, the
some published findings (Spriggs et al., 1992; Armitage expression of MMTV mRNA, a gene that is not involved
et al., 1993; Maliszewski et al., 1993), there are funda- in immunoglobulin secretion, was increased in response
mental differences between our assays and those that to LPS and IL-5 when CH12 cells were cocultured with
were used previously. For example, earlier studies gave either Lcells or gp39-expressing Lcells (Figure 6). These
no consideration to the effects of CD40-induced activa- data indicate that engagement of CD40 does not simply
tion and proliferation of B cells over the culture period repress the signaling cascades initiated from cytokine
(up to 10 days), and only measured total Ig accumulation and mitogen receptors and demonstrated that the ex-
in the cultures (Spriggs et al., 1992; Armitage et al., 1993; pression of secretory Ig genes was specifically re-
Durandy et al., 1993; Grabstein et al., 1993; Maliszewski pressed. This specific inhibition may have resulted from
et al., 1993). Thus, there was no way of knowing how CD40-mediated activation of repressor factors that bind
many cells contributed to the amount of accumulated to the promoter/enhancer regions of genes such as J
Ig. In contrast, our experiments measured the secretory chain, m, and BLIMP-1 (Lansford et al., 1992; Ernst and
rates of fixed numbers of B cells remaining at the end Smale, 1995; Rinkenberger et al., 1996). Alternatively,
of relatively short culture periods (2±4 days), thus, nor- CD40 engagement may either suppress, or never al-
malizing the effects of CD40-mediated activation and low, the activation of core regulatory genes, such as
proliferation. BLIMP-1, that are in turn required for differentiation.
We also observed that the persistence of the CD40 This explanation is attractive given that BLIMP-1 has
signal was necessary for the inhibition of differentia- been suggested to control both ms and J chain expres-
tion (Figure 3F) and that B cells can make a substantial sion (Turner et al., 1994), and the expression of BLIMP-1
recovery from the inhibitory effects of CD40 signaling mRNA is greatly reduced in gp39-stimulated cells (Fig-
within 24 hr after the signal is removed. Therefore, it is ure 5).
likely that earlier experiments using either fixed gp39-
expressing cells or soluble reagents induced the activa-
tion and proliferation of B cells during the first few days Role of CD40-Mediated Inhibition In Vivo
of culture and may have even inhibited Ig production Does the arrest of terminal differentiation and the sup-
during that time. However, once the CD40 signaling re- pression of antibody synthesis have a physiological
agent was depleted, the activated B cells were able significance? Other investigators have proposed that
to differentiate in response to the exogenously added signaling through CD40 drives B cells toward a memory
cytokines. cell phenotype (Arpin et al., 1995; Silvy et al., 1996).
Finally, we have shown that the reagents used to trig- Therefore, it is possible that B cells are preprogrammed
ger CD40 do not all produce equivalent signals. For
to differentiate into plasma cells in the presence of the
example, although the vast majority of gp39-transfected
appropriate inductive stimuli unless a sustained contact
cells inhibited differentiation, we did find one trans-
with gp39-expressing T cells alters the fate of the re-
fected cell line that failed to inhibit antibody secretion
sponding B cells and directs their differentiation into(Figure 3B). In addition, neither monoclonal nor poly-
memory cells (Arpin et al., 1997).clonal antibodies to CD40 could inhibit B cell differentia-
In addition, the inhibition of differentiation by CD40tion, even though they were perfectly capable of trig-
signaling may have a more immediate consequence ingering activation and proliferation (Figure 1). These
the germinal center. B cells are thought to encounterresults are consistent with a previous study showing
antigen-specific, gp39-expressing T cells initially in thethat monoclonal antibodies to human CD40 had variable
outer PALS (Foy et al., 1994), and then again in theabilities to inhibit B cell differentiation (Callard et al.,
germinal center (Han et al., 1995). Our data demonstrat-1995). Although it remains unclear why CD40 signaling
ing that the terminal differentiation of B cells is arrestedreagents differ in their biological properties, the fact that
upon sustained engagement of CD40 agree with thenormal activated T cells could completely inhibit B cell
published observations that antibody-secreting plasmadifferentiation in a gp39-specific fashion (Figure 4A) sug-
cells are not found in proximity to activated T cells ingests that the inhibitory effect is a physiological out-
either of these locations (Jacob et al., 1991; Jacobsoncome of sustained CD40 signaling.
et al., 1997). We propose that this active suppression
of antibody secretion may be beneficial for the expan-
sion and selection of high-affinity variants of antigen-Molecular Events Induced by CD40 Signaling
specific B cells in the germinal center. As the V regionsThe arrest of B cell differentiation mediated by cell-
bound gp39 was manifested at a molecular level as of the immunoglobulin genes become mutated, the B
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nonadherent BW5147 cell line was transfected by electroporationcells go through multiple rounds of selection. This selec-
using a BioRad Gene Pulser with a capacitance extender at 260 Vtion process requires the interaction of the antigen re-
and 960 mFa in 300 ml of complete media in a 0.4 cm gap cuvette.ceptor on B cells with antigen bound to follicular den-
Transfected cells were cultured for 48 hr and then selected in me-
dritic cells (Tew et al., 1997) as well as the interaction dium containing 1 mg/ml G418 (Geneticin, GIBCO). G418-resistant
of CD40 on B cells with gp39 on antigen-specific T cells clones were screened by FACS for gp39 expression.
(Liu et al., 1989). If high-affinity clones of B cells were
allowed to secrete antibodies while in the germinal cen- Coculture Conditions
CH12 cells were plated at 105 cells/ml and stimulated with the con-ter, the minute amounts of antigen that drive the selec-
centrations of cytokines and/or mitogens as indicated in the text.tion process would quickly become masked and selec-
Adherent cells were plated one day prior to the experiment to allowtion would become less efficient or even fail. Since
adherence while BW5147 cells were plated directly into coculture
plasma cells can produce up to 3000 antibody mole- experiments. Adherent cells and BW5147 cells were used at 105/ml
cules/cell/second (Fazekas de St. Groth and Scheideg- (or 1:1 initial ratio in the coculture system with CH12 cells).
ger, 1980; Randall et al., 1994), the masking would occur
rapidly within the close confines of the germinal center. T Cell Purification and Coculture
Naive CD41 T cells were purified from spleens and lymph nodes ofThus, signaling through CD40 may be required to main-
C57BL/6 mice by positive selection using anti-CD4 magnetic beadstain the undifferentiated state of germinal center B cells
(Miltenyi Biotec, Auburn CA). T cells were cocultured with CH12in order to facilitate affinity maturation. Our results are
cells in anti-CD3-coated wells (10 mg/ml in PBS for 2 hr). Cultures
consistent with this hypothesis as we observed that contained T cells at 5 3 105 cells/ml and CH12 cells at 105 cells/ml
the differentiation of antigen-specific germinal center B and were maintained for 48 hr.
cells was inhibited by CD40 engagement (Figure 4C).
Furthermore, while engagement of CD40 by cell-bound 3H-Thymidine Incorporation into B Cells
CH12 cells were plated in 96-well plates at 5 3 104 cells/well, withgp39 completely repressed J chain mRNA levels, it se-
the indicated stimuli and/or cocultured cells for 48 hr. Cells werelectively inhibited the production of ms but not mm (Figure
then pulsed with 1 mCi 3H-thymidine/well (NEN, Wilmington, DE) for5). Thus, while the secretory Ig products (ms and J chain)
4 hr, harvested, and the incorporated 3H-thymidine was determinedwould be repressed in the germinal center, the surface
by scintillation counting.
expression of the BCR would be maintained and could
drive the selection process. Purification of Naive and Germinal Center B Cells
Taken together, these results demonstrate that signal- Normal B cells were obtained from spleens from C57BL/6 mice.
Single cell suspensions of splenocytes were incubated with anti-ing through CD40 is not sufficient to induce B cell termi-
B220 magnetic beads (Miltenyi Biotech, Auburn, CA) and then posi-nal differentiation, and in fact, signals generated through
tively selected on a C-type magnetic column (Miltenyi) and usedCD40 can temporarily block the terminal differentiation
directly. Purity was assessed by FACS analysis and found to beof both normal B cells and B cell lines. Furthermore, the
95%±98% B2201 cells. To isolate germinal center B cells, C57BL/6
repression of the secretory Ig gene products is likely to mice were immunized i.p. with 100 mg (NP)30KLH adsorbed to alum.
be due, at least in part, to the decreased production of Ten days after immunization, splenocytes were obtained and
the regulatory factor BLIMP-1. We also suggest that stained with biotinylated antibodies to Mac-1, GR-1, Ter119, CD3,
CD4, CD8, DX5, IgD, and Syndecan. After washing, cells wereCD40-mediated inhibition of differentiation is likely to
stained with streptavidin-conjugated magnetic beads and appliedbe important in vivo as it provides a molecular mecha-
to a C-type MACS column. The resulting cells were highly enrichednism for the lack of antibody-secreting cells in the germi-
for germinal center B cells as judged by staining with PNA and anti-nal center and for the maintenance of the nonsecretory
B220 (30%±50%). The majority of contaminating cells were B2202
phenotype of memory B cells. cells of indeterminate origin.
Experimental Procedures Secretory Rates and ELISA
B cells were removed from any adherent cells after the indicated
Antibodies and Cytokines Used in Cell Culture culture period, washed twice in media, and counted. Cells were
Anti-CD40 antibodies were produced and purified as previously de- then replated at 105 cells/ml and allowed to secrete antibody for 6
scribed (Heath et al., 1994). Polyclonal goat-anti-mouse IgM Fab92 hr. Supernatants were harvested and Ig concentration was deter-
was purchased from Cappel (Durham, NC). The hamster anti-mouse mined by ELISA. Microtiter plates were coated with goat-anti-kappa
gp39 (MR1) was purified as described (Noelle et al., 1992a). The (Southern Biotechnology [SBA] Birmingham, AL), and developed
gp39-CD8 fusion protein was produced as described (Lane et al., with goat-anti-kappa-HRP (SBA).
1993). Recombinant mouse IL-2, IL-4, and IL-10 were all prepared
by DNAX Research Institute. IL-5 and IL-6 were purchased from
Northern BlotsGenzyme, Cambridge, MA and LPS (E. coli 055:B5) was purchased
RNA was isolated from cells using the Lithium Chloride methodfrom Difco, Detroit, MI.
(Auffray and Rougeon, 1980). Twenty micrograms of total RNA was
run on a formaldehyde gel and blotted to reinforced nitrocelluloseCell Lines and Cell Culture
(MSI, Westborough, MA). Blots were probed with cDNAs of theThe B cell lymphoma CH12 was maintained by weekly passage as
zinc-finger transcription factor BLIMP-1 (Turner et al., 1994), thean ascites tumor in B10.A mice. The cell lines BW5147, J558, A20,
mitochondrial enzyme CHO-B as a loading control, the LTR region293, 3T3, and CHO cells were obtained from the ATCC (Rockville,
of Mtv-9, the immunoglobulin J chain, and the constant region ofMD), and BHK, Cos-7, and L cells were a gift of Kevin Moore (DNAX
m (Randall et al., 1994).Research Institute). All cells were maintained in RPMI supplemented
with MEM vitamins, MEM nonessential amino acids, glucose, gluta-
Acknowledgmentsmine, penicillin, streptomycin, and 10% FBS all from GIBCO (Grand
Island, NY).
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